search
Back to results

The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes (ENHANCED1)

Primary Purpose

Type 1 Diabetes

Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Activity tracker and chest strap
Diary app
Sponsored by
prof dr Pieter Gillard
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Type 1 Diabetes focused on measuring Physical activity, Artificial intelligence

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Signed informed consent 18-80 years old Type 1 diabetes ≥1 year Using a CGM for more than 6 months Using insulin (insulin pens, insulin pumps or hybrid closed-loop systems) to manage glycaemia for more than 6 months No use of adjunctive therapies, such as SGLT2-inhibitors or GLP-1 analogues No known diabetic gastroparesis HbA1c of the last two diabetes consultations are both <10% Being physically active at least twice a week on two separate days for 30 consecutive minutes Exclusion Criteria: Age <18 years or >80 years People with type 2 diabetes, people with secondary diabetes Begin treatment with insulin (insulin pens, insulin pumps or hybrid closed-loop systems) less than 6 months before inclusion Not using CGM prior to inclusion Known diabetic gastroparesis HbA1c > 10% during one of the last two diabetes consultations Not willing to use an activity tracker, the diary app or the food app Not being physically active on a regular basis

Sites / Locations

  • UZ LeuvenRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Physically active participants

Arm Description

There is only one study arm, namely all participants are subjected to the same interventions.

Outcomes

Primary Outcome Measures

Database which contains insulin data (insulin dose over time) retrieved from diabetes management platforms.
Database which contains glucose data (glycemic values over time) retrieved from diabetes management platforms.
Database which contains physical activity data (type of activity) retrieved from the activity tracker and chest strap.
Database which contains physical activity data (intensity of activity) retrieved from the activity tracker and chest strap.
Database which contains physical activity data (duration of activity) retrieved from the activity tracker and chest strap.
Database which contains food intake data (timing of food) retrieved from the diary app.
Database which contains food intake data (amount of food in grams) retrieved from the diary app.
Database which contains food intake data (type of food) retrieved from the diary app.

Secondary Outcome Measures

Full Information

First Posted
August 29, 2022
Last Updated
December 20, 2022
Sponsor
prof dr Pieter Gillard
Collaborators
University Colleges Leuven Limburg
search

1. Study Identification

Unique Protocol Identification Number
NCT05670366
Brief Title
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
Acronym
ENHANCED1
Official Title
Proof-of-concept Study for the Integration of Physical Activity Into the Clinical Decision Process of Physically Active People With Type 1 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 26, 2022 (Actual)
Primary Completion Date
March 1, 2023 (Anticipated)
Study Completion Date
March 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
prof dr Pieter Gillard
Collaborators
University Colleges Leuven Limburg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Every person with type 1 diabetes needs personalized advice to integrate physical activity into daily diabetes management. The purpose of this study is to collect data on food intake, physical activity, glucose levels and insulin delivery from people with type 1 diabetes who are physically active. At least 25 people with type 1 diabetes will be asked to perform 25 sports activities of at least half an hour, wear an activity tracker (day and night) and chest strap (during sports activities), and log data on food intake, periods and type of physical activity, and feelings (e.g., sick, stress) in a diary app. Diabetes data such as insulin administration and sensor data will be collected through diabetes management platforms. The primary endpoint involves a database containing data on glucose, insulin administration, physical activity, and food intake of people with type 1 diabetes for statistical analyses and visualizations regarding the relationship between physical activity and blood glucose response.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes
Keywords
Physical activity, Artificial intelligence

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Physically active participants
Arm Type
Other
Arm Description
There is only one study arm, namely all participants are subjected to the same interventions.
Intervention Type
Device
Intervention Name(s)
Activity tracker and chest strap
Intervention Description
During the study, the participants will be asked to wear a commercially-available activity tracker during day and night, and a chest strap during sport activities to collect data on physical activity (type, intensity and duration of activity).
Intervention Type
Device
Intervention Name(s)
Diary app
Intervention Description
During the study, the participants will be asked to log the ingestion of carbohydrates, periods and type of physical activity, feelings (e.g. sick, stress, ...) in a diary app.
Primary Outcome Measure Information:
Title
Database which contains insulin data (insulin dose over time) retrieved from diabetes management platforms.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains glucose data (glycemic values over time) retrieved from diabetes management platforms.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains physical activity data (type of activity) retrieved from the activity tracker and chest strap.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains physical activity data (intensity of activity) retrieved from the activity tracker and chest strap.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains physical activity data (duration of activity) retrieved from the activity tracker and chest strap.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains food intake data (timing of food) retrieved from the diary app.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains food intake data (amount of food in grams) retrieved from the diary app.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks
Title
Database which contains food intake data (type of food) retrieved from the diary app.
Time Frame
Through study completion (after 25 sport activities), an average of 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Signed informed consent 18-80 years old Type 1 diabetes ≥1 year Using a CGM for more than 6 months Using insulin (insulin pens, insulin pumps or hybrid closed-loop systems) to manage glycaemia for more than 6 months No use of adjunctive therapies, such as SGLT2-inhibitors or GLP-1 analogues No known diabetic gastroparesis HbA1c of the last two diabetes consultations are both <10% Being physically active at least twice a week on two separate days for 30 consecutive minutes Exclusion Criteria: Age <18 years or >80 years People with type 2 diabetes, people with secondary diabetes Begin treatment with insulin (insulin pens, insulin pumps or hybrid closed-loop systems) less than 6 months before inclusion Not using CGM prior to inclusion Known diabetic gastroparesis HbA1c > 10% during one of the last two diabetes consultations Not willing to use an activity tracker, the diary app or the food app Not being physically active on a regular basis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pieter Gillard, MD, PhD
Phone
016 340615
Email
pieter.gillard@uzleuven.be
First Name & Middle Initial & Last Name or Official Title & Degree
Jolien De Meulemeester, Msc
Phone
016 344138
Email
jolien.demeulemeester@uzleuven.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pieter Gillard, MD, PhD
Organizational Affiliation
UZ Leuven
Official's Role
Principal Investigator
Facility Information:
Facility Name
UZ Leuven
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jolien De Meulemeester, Msc
Phone
016 344138
Email
jolien.demeulemeester@uzleuven.be

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes

We'll reach out to this number within 24 hrs